Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-102 Combined With Nedaplatin in Advanced Gastric or GEJ Adenocarcinoma
NCT07913165Phase 2Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Dec 2027
01
Overview
A Phase 2 trial of trifluridine + tipiracil, nedaplatin in gastric cancer (GC), gastroesophageal junction adenocarcinoma. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
trifluridine + tipiracilnedaplatin
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07913165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913165.